The efficacy of sclerosing injections in the treatment of painful tendinopathy

Physical Therapy Reviews

Volumn 16, Issue 4, 2011, Pages 244-260

  Wilde, Benjamin ^a   Havill, Andrea ^b   Priestley, Leanne ^c   Lewis, Jeremy ^c   Kitchen, Sheila ^d  

^a Physio More Ltd   (United Kingdom)

^b PURE SPORTS MEDICINE   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Injections; Neovascularization; Pain; Polidocanol; Sclerosing; Tendinopathy

Indexed keywords

EID: 84880299017     PISSN: 10833196     EISSN: 1743288X     Source Type: Journal    
DOI: 10.1179/1743288X11Y.0000000025     Document Type: Article

References (62)

1. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med 2009;43:409–16.
2. Khan K, Cook J, Taunton J, Bonar F. Overuse tendinosis, not tendinitis. Phys Sports Med 2000;28:1–9.
3. Alfredson H, Lorentzon R. Chronic Achilles tendinosis: recommendations for treatment and prevention. Sports Med 2000;29:135–46.
4. Peers KH, Lysens RJ. Patellar tendinopathy in athletes: current diagnostic and therapeutic recommendations. Sports Med 2005;35:71–87.
5. van Mechelen W, Twisk J, Molendijk A, Blom B, Snel J, Kemper HC. Subject-related risk factors for sports injuries: a 1-yr prospective study in young adults. Med Sci Sports Exercise 1996;28:1171–9.
6. Ljung B, Forsgren S, Friden J. Substance P and calcitonin gene-related peptide expression at the extensor carpi radialis brevis muscle origin: implications for the etiology of tennis elbow. J Orthop Res 1999;17:554–9.
7. Gaida JE, Alfredson L, Kiss ZS, Wilson AM, Alfredson H, Cook JL. Dyslipidemia in Achilles tendinopathy is characteristic of insulin resistance. Med Sci Sports Exercise 2009;41:1194–7.
8. Davidson JH, Vandervoort A, Lessard L, Miller L. The effect of acupuncture versus ultrasound on pain level, grip strength and disability in individuals with lateral epicondylitis: a pilot study. Physiother Can 2001;53:195–202.
9. Perugia L, Postacchini F, Ippolito E. The tendons: biology, pathology, clinical aspects. 1st ed. Milano: Editrice Kurtis; 1986.
10. Khan KM, Maffulli N, Puddu G. Tendinopathy: an Achilles’ heel for athletes and clinicians. Clin J Sports Med 1998;8:151–4.
11. Maffulli N, Khan K, Puddu G. Overuse tendon conditions: time to change a confusing terminology. Arthroscopy 1998;14:840–3.
12. Ljung B, Alfredson H. Forsgren S. Neurokinin 1-receptors and sensory neuropeptides in tendon insertions at the medial and lateral epicondyles of the humerus. Studies on tennis elbow and medial epicondylalgia. J Orthop Res 2004;22:321–7.
13. Bjur D, Alfredson H, Forsgren S. The innervation pattern of the human Achilles tendon: studies of the normal and tendinosis tendon with markers for general and sensory innervations. Cell Tissue Res 2005;320:201–6.
14. Forsgren S, Danielson P, Alfredson H. Vascular NK-1 receptor occurrence in normal and chronic painful Achilles and patellar tendons: studies on chemically unfixed as well as fixed specimens. Regul Pept 2005;26:173–81.
15. Carlstedt CA, Nordin M. Biomechanics of tendons and ligaments. In:, Nordin M, Frankel V H, ed, editors. Basic biomechanics of the musculoskeletal system. 2nd ed. Philadelphia, PA: Lea and Febiger; 1989.
16. Taunton J, Clement D, McKenzie D, Davidson R. Achilles tendonitis in runners. Med Sci Sports Exercise 1985;17:224.
17. Kvist MH, Jozsa L, Jarvinen MJ, Kvist H. Chronic Achilles paratenonitis in athletes: a histological and histochemical study. Pathology 1987;19:1–11.
18. Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M. Histopathology of common tendinopathies: update and implications for clinical management. Sports Med 1999;27:393–408.
19. Soslowsky LJ, Thomopoulos S, Esmail A, Flanagan CL, Iannotti JP, Williamson JD, et al. Rotator cuff tendinosis in an animal model: role of extrinsic and overuse factors. Ann Biomed Eng 2002;30:1057–63.
20. Saltsman CL, Tearse DS. Achilles tendon injuries. J Am Acad Orthop Surgeons 1998;6:316–25.
21. Gaida JE, Cook JL, Bass SL. Adiposity and tendinopathy. Disabil Rehabil 2008;30:1555–62.
22. Ljung B, Forsgren S, Friden J. Sympathetic and sensory innervations are heterogeneously distributed in relation to the blood vessels at the extensor carpi radialis brevis muscle origin of man. Cells Tissues Organs 1999;165:45–54.
23. Xu XJ, Wiesenfeld-Hallin Z. The differential roles of substance P and neurokinin A in spinal cord hyperexcitability and neurogenic inflammation. Regul Pept 1993;46:165–73.
24. Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 1990;40:264–78.
25. Fan TP, Hu DE, Guard S, Gresham A, Watling KJ. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 1993;110:43–9.
26. Alfredson H, Thorsen K, Lorentzon R. In situ microdialysis in tendon tissue: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain. Knee Surg Sports Traumatol Arthrosc 1999;7:378–81.
27. Haegerstrand A, Laurenzi MA, Persson MA, Dalsgaard C. The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: activated cells are preferentially influenced by the neuropeptide. Scand J Immunol 1990;31:529–33.
28. Khan KM, Cook JL, Maffulli N, Kannus P. Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin. Br J Sports Med 2000;34:81–3.
29. Knobloch K, Gohritz A, Spies M, Vogt PM. Neovascularisation in de Quervain’s disease of the wrist: novel combined therapy using sclerosing therapy with polidocanol and eccentric training of the forearms and wrists — a pilot report. Knee Surg Sports Traumatol Arthrosc 2008;16:803–5.
30. Alfredson H, Ohberg L, Lorentzon R. Neovascularisation in Achilles tendons with painful tendinosis but not in normal tendons: an ultrasonographic investigation. Knee Surg Sports Traumatol Arthrosc 2001;9:233–8.
31. Alfredson H, Cook J. A treatment algorithm for managing Achilles tendinopathy: new treatment options. Br J Sports Med 2007;41:211–6.
32. Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does not, and what is on the horizon. Clin Orthop Relat Res 2008;466:1539–54.
33. Haegerstrand A, Laurenzi MA, Persson MA, Dalsgaard C. The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: activated cells are preferentially inluenced by the neuropeptide. Scand J Immunol 1990;31:529–33.
34. Coleman BD, Khan KM, Young DA, Bartlett J, Cook JL, Wark JD, et al. Comparison of open and arthroscopic patellar tendon surgery for jumper’s knee: 4 year clinical and ultrasonographic follow up. Med Sci Sports Exercise 1999;31(Suppl. 5):S294.
35. Maffulli N, Longo UG. Conservative management for tendinopathy: is there enough scientific evidence? Rheumatology 2008;47:390–1.
36. Mimura H, Fujiwara H, Hiraki T, Gobara H, Muka T, Hyodo T, et al. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief. Eur Radiol 2009;19:2474–80.
37. Jain R, Bandhu S, Sawhney S, Mittal R. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 2002;30:416–23.
38. Liberati A, Altman, Tetzlaff J, Mulrow C, Gøtzsche P, Ionnidis J, et al. The PRISMA statement for reporting systematic reviews and meta-analysis of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
39. CRD (Centre for Reviews and Dissemination). York: The University of York Press; 2001.
40. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health 1998;52:377–84.
41. Moore A. What is a NNT? Statistics, 2nd ed. Oxford: Hayward Group Ltd; 2009.
42. Alfredson H, Ohberg L. Sclerosing injections to areas of neo-vascularisation reduce pain in chronic Achilles tendinopathy: a double-blind randomised controlled trial. Knee Surg Sports Traumatol Arthrosc 2005;13:338–44.
43. Zeisig E, Fahlstrom M, Ohberg L, Alfredson H. Pain relief after intratendinous injections in patients with tennis elbow: results of a randomised study. Br J Sports Med 2008;42:267–71.
44. Hoksrud A, Ohberg L, Alfredson H, Bahr R. Ultrasound-guided sclerosis of neovessels in painful chronic patellar tendinopathy: a randomized controlled trial. Am J Sports Med 2006;34:1738–46.
45. Lind B, Ohberg L, Alfredson H. Sclerosing polidocanol injections in mid-portion Achilles tendinosis: remaining good clinical results and decreased tendon thickness at 2-year follow-up. Knee Surg Sports Traumatol Arthrosc 2006;14:1327–32.
46. Alfredson H, Ohberg L, Zeisig E, Lorentzon R. Treatment of midportion Achilles tendinosis: similar clinical results with US and CD-guided surgery outside the tendon and sclerosing polidocanol injections. Knee Surg Sports Traumatol Arthrosc 2007;15:1504–9.
47. Willberg L, Sunding K, Ohberg L, Forssblad M, Fahlstrom M, Alfredson H. Sclerosing injections to treat midportion Achilles tendinosis: a randomised controlled study evaluating two different concentrations of Polidocanol. Knee Surg Sports Traumatol Arthrosc 2008;16:859–64.
48. Ohberg L, Alfredson H. Ultrasound guided sclerosis of neovessels in painful chronic Achilles tendinosis: pilot study of a new treatment. Br J Sports Med 2002;36:173–5.
49. Zeisig E, Ohberg L, Alfredson H. Sclerosing polidocanol injections in chronic painful tennis elbow-promising results in a pilot study. Knee Surg Sports Traumatol Arthrosc 2006;14:1218–24.
50. Ohberg L, Alfredson H. Sclerosing therapy in chronic Achilles tendon insertional pain-results of a pilot study. Knee Surg Sports Traumatol Arthrosc 2003;11:339–43.
51. Visentini PJ, Khan KM, Cook JL, Kiss ZS, Harcourt PR, Wark JD. The VISA score: an index of severity of symptoms in patients with jumper’s knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport 1998;1:22–8.
52. Hoksrud A, Ohberg L, Alfredson H, Bahr R. Color Doppler ultrasound findings in patellar tendinopathy (jumper’s knee). Am J Sports Med 2008;36:1813–20.
53. McQuay H, Moore A. An evidence-based resource for pain relief. Estimating relative effectiveness. Bath: Oxford University Press; 1998.
54. Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. Spine 1989;14:962–4.
55. Alfredson H, Ohberg L. Neovascularisation in chronic painful patellar tendinosis–promising results after sclerosing neovessels outside the tendon challenge the need for surgery. Knee Surg Sports Traumatol Arthrosc 2005;13:74–80.
56. Lewis JS, Raza SA, Pilcher J, Heron C, Poloniecki JD. The prevalence of neovascularity in patients clinically diagnosed with rotator cuff tendinopathy. BMC Musculoskelet Disord 2009;10:163.
57. Cook JL, Malliaras P, de Luca J, Ptasznik R, Morris ME, Goldie P. Neovascularization and pain in abnormal patellar tendons of active jumping athletes. Clin J Sport Med 2004;14:296–9.
58. Adler RS, Fealy S, Rudzki JR, Kadrmas W, Verma NN, Pearle A, et al. Rotator cuff in asymptomatic volunteers: contrast-enhanced US depiction of intratendinous and peritendinous vascularity. Radiology 2008;248:954–61.
59. du Toit C, Stieler M, Saunders R, Bisset L, Vicenzino B. Diagnostic accuracy of power Doppler ultrasound in patients with chronic tennis elbow. Br J Sports Med. 2008;42:572–6.
60. Peers KH, Brys PP, Lysens RJ. Correlation between power Doppler ultrasonography and clinical severity in Achilles tendinopathy. Int Orthop 2003;27:180–3.
61. The Cochrane Collaboration. 2006, Cochrane handbook for systematic reviews of interventions [document on the Internet]. The Cochrane Collaboration; 2006. Available from http://209·211·250·105
62. Crombie IK, Davies HT. What is meta-analysis? Evidence-based medicine, 2nd ed. Oxford: Hayward Group Ltd; 2009.